Company Overview

Update
Founded:
2007
Founders:
Samir Patel
Headquarters:
Princeton, NJ
IPO:
Went Public
Stock:
NASDAQ:OPHT
Categories:
Biotechnology

Ophthotech is a biopharmaceutical company developing novel therapies for age-related macular degeneration.

Description

Update

Ophthotech Corporation, a biopharmaceutical company, develops various therapeutics to treat diseases of the eye. It is developing Fovista, which has completed Phase IIb clinical trials for use in combination with anti-VEGF drugs for the treatment of wet age-related macular degeneration (wet AMD); and ARC1905, a potent and selective inhibitor of complement factor C5 that has completed Phase I/IIa clinical trials to treat wet AMD. The company was founded in 2007 and is headquartered in New York, New York.

Current Team (11)

Update

Board Members and Advisors (6)

Update

Funding Rounds (4) - $246.70M

Update

Investors (4)

Update
  • 833227dddcb31df78412232c4596d5ad

    SV Life Sciences

    Venture capital Firm
  • 0c6b7d3c490ac6ea1f104fc09cda3f3f

    Novo A/S

    Novo A/S is the holding company of the Novo Group, wholly-owned by the Novo Nordisk Foundation.
  • Dee8000cd83a2bd29b5b518f3e0ad2c2

    HBM BioVentures

    As a venture capital company, HBM BioVentures is invested globally in some 40 mature emerging..
  • Ecd7e24dcc0b6edd2833c7a732da1b25

    Clarus Ventures

    Clarus Ventures is a life sciences venture capital firm.

Offices/Locations (2)

Update
  • Office

    One Penn Plaza

    35th Floor

    New York, NY 10119

    USA

  • Office

    5 Vaughn Drive

    Suite 106

    Princeton, NJ 08540

    USA

Images (1)

Update
  • 276ef2a92151a45ee9f9f23412fd6e7d